Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

Fostering Higher Foreign Contributions to Pharma R&D Through Trade Deals, Deregulation and Aligning Incentives

October 7, 2026

SSRN

By Satya Marar, Alden F. Abbott

Mandatory Value-Based Payment Programs and Hospital Administrative Costs

August 18, 2026

JAMA Health Forum

By Zehui Zhou, MPH, Jason D. Buxbaum, PhD, Andrew M. Ryan, PhD

The Impact of Price Controls on Longterm Prescription Drug Prices

August 13, 2026

The University of Chicago

By Tomas J. Philipson, Deyu Zhang, Noah Fisher, and Cyrus Seyrafi

Profitability Of Infused Biologics For Hospitals And Physician Practices: Case Study Of Keytruda

August 5, 2026

Health Affairs

By James C. Robinson,, Ari Kosorukuv, Mark Thomson, and Christopher M. Whaley

Assessing The Value Of Post-Approval Research For U.S. Policy Makers

July 29, 2026

Health Affairs

By Dan Crippen and Kirsten Axelsen
Scroll to Top